Clinical Trials Directory

Trials / Unknown

UnknownNCT04685460

3D Printed Bolus in Post-mastectomy Radiotherapy

Clinical Study of 3D Printed Bolus for Volumetric Modulated Arc Therapy of Post-mastectomy Treatment

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Jiangxi Provincial Cancer Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Recently, there is growing interest in the application of three-dimensional (3D) printed bolus to radiotherapy.At present, the researches on the application of 3D-printed bolus in breast cancer are mainly focused on air gap between skin and bolus or electron beam conformal therapy \[7,15\], there are no clinical experience with customized 3D-printed bolus for volumetric modulated arc therapy (VMAT) in daily practice has been published up to now. We aim to evaluate dosimetry and application of 3D-printed bolus for the post-mastectomy radiotherapy (PMRT) with Volumetric modulated arc therapy (VMAT). Seventy five patients with breast cancer receiving radiotherapy following post-mastectomy in our department were randomly selected in this study. The accuracy of fit of the 3D-Printed bolus to the chest wall was improved significantly relative to conventional bolus.This study demonstrates customized 3D-printed bolus in post-mastectomy radiation therapy improves fit of the bolus compared to conventional bolus. Furthermore, VMAT based on 3D-printed bolus significantly improves the chest wall target coverage and the conformity of plan, and reduces the dose of ipsilateral lung and heart, compared to conventional bolus.

Conditions

Interventions

TypeNameDescription
OTHERcustomized 3D-printed bolus fabricated based on reconstruction of computed tomography (CT) imagescustomized 3D-printed bolus fabricated based on reconstruction of computed tomography (CT) images were used in this study.

Timeline

Start date
2020-03-01
Primary completion
2021-04-15
Completion
2021-04-20
First posted
2020-12-28
Last updated
2021-04-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04685460. Inclusion in this directory is not an endorsement.